Medical Marijuana Erodes “Zero Tolerance” Federal Drug Policy

Tasha Patterson@Work


Medical Marijuana

The medical marijuana movement is beginning to drive public policy in ways that may erode the federal “zero tolerance” policy against marijuana in the workplace.

The Drug Enforcement Administration (DEA) is expected to announce soon whether it will reclassify marijuana from Schedule I (the most restricted drugs) to Schedule II under the Controlled Substances Act. The DEA has promised an announcement about this “in the first half” of 2016.

Full content is available to DMEC members only. Log in to view the complete resource.

If you are not a DMEC member, we encourage you to join. DMEC members have access to white papers, case studies, @Work magazine articles, free webinars, legislative updates, and much more. These resources will assist you in building an effective and compliant integrated absence management program, saving you time, resources, and money. Learn more.

If you are being asked to log in more than once, please refresh your browser.